Abstract
A new variant of antithrombin (Rouen-VI, 187 Asn-->Asp) with increased heparin affinity was shown to have normal inhibitory activity which decreased slowly at 4 degrees C and rapidly at 41 degrees C. On electrophoresis the freshly isolated variant had an anodal shift relative to native antithrombin due to the mutation. A further anodal transition occurred after either prolonged storage at 4 degrees C or incubation at 41 degrees C due to the formation of a new inactive uncleaved component with properties characteristic of L-form (latent) antithrombin. At the same time, polymerization also occurred with a predominance of di-, tri-, and tetra-mers. These findings fit with the observed mutation of the conserved asparagine (187) in the F-helix destabilizing the underlying A-sheet of the molecule. Evidence of A-sheet perturbation is provided by the increased rate of peptide insertion into the A-sheet and by the decreased vulnerability of the reactive loop to proteolysis. The spontaneous formation of both L-antithrombin and polymers is consistent with our crystal structure of intact antithrombin where L-form and active antithrombin are linked together as dimers. The nature of this linkage favors a mechanism of polymerization whereby the opening of the A-sheet, to give incorporation of the reactive center loop, is accompanied by the bonding of the loop of one molecule to the C-sheet of the next. The accelerated lability of antithrombin Rouen-VI at 41 versus 37 degrees C provides an explanation for the clinical observation that episodes of thrombosis were preceded by unrelated pyrexias.
Full text
PDF![2265](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/c1d6886ea2a4/jcinvest00490-0095.png)
![2266](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/1df7576fedef/jcinvest00490-0096.png)
![2267](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/7f427a56bfd7/jcinvest00490-0097.png)
![2268](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/9f724b2991b8/jcinvest00490-0098.png)
![2269](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/9d69e6d53747/jcinvest00490-0099.png)
![2270](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/726b6449e9af/jcinvest00490-0100.png)
![2271](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/ccbeda1f4881/jcinvest00490-0101.png)
![2272](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/e4affd30d28c/jcinvest00490-0102.png)
![2273](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/33c28ef2ab25/jcinvest00490-0103.png)
![2274](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe2/330053/5e9f6de292d9/jcinvest00490-0104.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abildgaard U., Lie M., Odegård O. R. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res. 1977 Oct;11(4):549–553. doi: 10.1016/0049-3848(77)90208-0. [DOI] [PubMed] [Google Scholar]
- Aulak K. S., Eldering E., Hack C. E., Lubbers Y. P., Harrison R. A., Mast A., Cicardi M., Davis A. E., 3rd A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem. 1993 Aug 25;268(24):18088–18094. [PubMed] [Google Scholar]
- Baumann U., Huber R., Bode W., Grosse D., Lesjak M., Laurell C. B. Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J Mol Biol. 1991 Apr 5;218(3):595–606. doi: 10.1016/0022-2836(91)90704-a. [DOI] [PubMed] [Google Scholar]
- Carrell R. W., Evans D. L., Stein P. E. Mobile reactive centre of serpins and the control of thrombosis. Nature. 1991 Oct 10;353(6344):576–578. doi: 10.1038/353576a0. [DOI] [PubMed] [Google Scholar]
- Carrell R. W., Owen M. C. Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature. 1985 Oct 24;317(6039):730–732. doi: 10.1038/317730a0. [DOI] [PubMed] [Google Scholar]
- Carrell R. W., Stein P. E., Fermi G., Wardell M. R. Biological implications of a 3 A structure of dimeric antithrombin. Structure. 1994 Apr 15;2(4):257–270. doi: 10.1016/s0969-2126(00)00028-9. [DOI] [PubMed] [Google Scholar]
- Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem. 1970 Jun;245(12):3059–3065. [PubMed] [Google Scholar]
- Huber R., Carrell R. W. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry. 1989 Nov 14;28(23):8951–8966. doi: 10.1021/bi00449a001. [DOI] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
- Lesk A. M., Hardman K. D. Computer-generated schematic diagrams of protein structures. Science. 1982 Apr 30;216(4545):539–540. doi: 10.1126/science.7071602. [DOI] [PubMed] [Google Scholar]
- Loebermann H., Tokuoka R., Deisenhofer J., Huber R. Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol. 1984 Aug 15;177(3):531–557. [PubMed] [Google Scholar]
- Lomas D. A., Evans D. L., Stone S. R., Chang W. S., Carrell R. W. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry. 1993 Jan 19;32(2):500–508. doi: 10.1021/bi00053a014. [DOI] [PubMed] [Google Scholar]
- Lomas D. A., Finch J. T., Seyama K., Nukiwa T., Carrell R. W. Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem. 1993 Jul 25;268(21):15333–15335. [PubMed] [Google Scholar]
- Mast A. E., Enghild J. J., Pizzo S. V., Salvesen G. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry. 1991 Feb 12;30(6):1723–1730. doi: 10.1021/bi00220a039. [DOI] [PubMed] [Google Scholar]
- Mast A. E., Enghild J. J., Salvesen G. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry. 1992 Mar 17;31(10):2720–2728. doi: 10.1021/bi00125a012. [DOI] [PubMed] [Google Scholar]
- McKay E. J. A simple two-step procedure for the isolation of antithrombin III from biological fluids. 1981 Feb 15-Mar 1Thromb Res. 21(4-5):375–382. doi: 10.1016/0049-3848(81)90138-9. [DOI] [PubMed] [Google Scholar]
- Mottonen J., Strand A., Symersky J., Sweet R. M., Danley D. E., Geoghegan K. F., Gerard R. D., Goldsmith E. J. Structural basis of latency in plasminogen activator inhibitor-1. Nature. 1992 Jan 16;355(6357):270–273. doi: 10.1038/355270a0. [DOI] [PubMed] [Google Scholar]
- Mourey L., Samama J. P., Delarue M., Petitou M., Choay J., Moras D. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. J Mol Biol. 1993 Jul 5;232(1):223–241. doi: 10.1006/jmbi.1993.1378. [DOI] [PubMed] [Google Scholar]
- Nordenman B., Björk I. Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies. Biochemistry. 1978 Aug 8;17(16):3339–3344. doi: 10.1021/bi00609a026. [DOI] [PubMed] [Google Scholar]
- Nordenman B., Nyström C., Björk I. The size and shape of human and bovine antithrombin III. Eur J Biochem. 1977 Aug 15;78(1):195–203. doi: 10.1111/j.1432-1033.1977.tb11730.x. [DOI] [PubMed] [Google Scholar]
- Olson S. T., Srinivasan K. R., Björk I., Shore J. D. Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction. J Biol Chem. 1981 Nov 10;256(21):11073–11079. [PubMed] [Google Scholar]
- Perry D. J., Harper P. L., Fairham S., Daly M., Carrell R. W. Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reaction. FEBS Lett. 1989 Aug 28;254(1-2):174–176. doi: 10.1016/0014-5793(89)81033-6. [DOI] [PubMed] [Google Scholar]
- Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed] [Google Scholar]
- Rovelli G., Stone S. R., Guidolin A., Sommer J., Monard D. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1. Biochemistry. 1992 Apr 7;31(13):3542–3549. doi: 10.1021/bi00128a031. [DOI] [PubMed] [Google Scholar]
- Schreuder H. A., de Boer B., Dijkema R., Mulders J., Theunissen H. J., Grootenhuis P. D., Hol W. G. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat Struct Biol. 1994 Jan;1(1):48–54. doi: 10.1038/nsb0194-48. [DOI] [PubMed] [Google Scholar]
- Stein P. E., Leslie A. G., Finch J. T., Turnell W. G., McLaughlin P. J., Carrell R. W. Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature. 1990 Sep 6;347(6288):99–102. doi: 10.1038/347099a0. [DOI] [PubMed] [Google Scholar]
- Stein P., Chothia C. Serpin tertiary structure transformation. J Mol Biol. 1991 Sep 20;221(2):615–621. doi: 10.1016/0022-2836(91)80076-7. [DOI] [PubMed] [Google Scholar]
- Verpy E., Couture-Tosi E., Tosi M. C1 inhibitor mutations which affect intracellular transport and secretion in type I hereditary angioedema. Behring Inst Mitt. 1993 Dec;(93):120–124. [PubMed] [Google Scholar]
- Wardell M. R., Abrahams J. P., Bruce D., Skinner R., Leslie A. G. Crystallization and preliminary X-ray diffraction analysis of two conformations of intact human antithrombin. J Mol Biol. 1993 Dec 20;234(4):1253–1258. doi: 10.1006/jmbi.1993.1676. [DOI] [PubMed] [Google Scholar]
- Wei A., Rubin H., Cooperman B. S., Christianson D. W. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Nat Struct Biol. 1994 Apr;1(4):251–258. doi: 10.1038/nsb0494-251. [DOI] [PubMed] [Google Scholar]
- Wright H. T., Qian H. X., Huber R. Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor. J Mol Biol. 1990 Jun 5;213(3):513–528. doi: 10.1016/s0022-2836(05)80212-8. [DOI] [PubMed] [Google Scholar]